- 2023.09.27Research News
Research news: EME successfully constructs CAR-T with VHH antibodies, The in vitro experiment showed the secretion of IL-2 from EME’s VHH-based CAR-T cell.
Northwestern University experts published to Nature “Mega-scale experimental analysis of protein folding stability in biology and design” in July 2023. The research team utilized EME’s cnvK linker for development of cDNA display proteolysis method.
- 2023.07.28Press Release
EME entered into a comprehensive collaboration agreement with Kao for Multiple Infectious Diseases with Utilizing PharmaLogical™ VHH.
【Overseas Event】EME will join Bio international Convention 2023
- 2023.02.07Press Release
EME and ASKA Announce Collaboration Agreement on Creating Novel PharmaLogical® VHH to address an unmet medical need in Obstetrics and Gynecology
About business during the year-end and New Year holidays
【Event】EME will exhibit at Japan Healthcare Venture Summit (JHVS) 2022
【Overseas Event】EME will join Bio international Convention 2022
【Overseas Event】EME will attend 18th Annual PEGS BOSTON Conference & Expo
- 2022.03.03Press Release
EME PUBLISHES NOVEL HUMANIZED SYNTHETIC VHH LIBRARY “PharmaLogical® Library” FOR THERAPEUTIC ON ANTIBODIES JORNAL.